Safety and efficacy of glucagon-like peptide 1 receptor agonists in patients With cirrhosis.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Abstract
No abstract availableCitation
Morris SM, Armstrong MJ, Newsome PN. Safety and Efficacy of Glucagon-like Peptide 1 Receptor Agonists in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2022 Jun;20(6):1220-1222. doi: 10.1016/j.cgh.2021.09.023. Epub 2021 Sep 22Type
OtherAdditional Links
http://www.sciencedirect.com/science/journal/15423565PMID
34560279Publisher
W.B. Saundersae974a485f413a2113503eed53cd6c53
10.1016/j.cgh.2021.09.023